US4450150A
(en)
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
JPH0680077B2
(ja)
|
1985-02-08 |
1994-10-12 |
サントリー株式会社 |
プロリンエンドペプチダ−ゼインヒビタ−活性を有する新規ペプチド化合物
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
US5750646A
(en)
|
1987-09-24 |
1998-05-12 |
The Administrators Of The Tulane Educational Fund |
Bradykinin analogs with non-peptide bond
|
US4879278A
(en)
|
1989-05-16 |
1989-11-07 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
|
US4939168A
(en)
|
1989-08-11 |
1990-07-03 |
Harbor Branch Oceanographics Institution, Inc. |
Discodermolide compounds, compositions containing same and methods of preparation and use
|
US5010099A
(en)
|
1989-08-11 |
1991-04-23 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds, compositions containing same and method of preparation and use
|
GB9016810D0
(en)
|
1990-07-31 |
1990-09-12 |
Wellcome Found |
Peptides
|
JPH04208299A
(ja)
|
1990-11-30 |
1992-07-29 |
Ajinomoto Co Inc |
プロリルエンドペプチターゼ阻害ペプチド
|
US5387671A
(en)
|
1990-12-27 |
1995-02-07 |
Abbott Laboratories |
Hexa- and heptapeptide anaphylatoxin-receptor ligands
|
EP0598129B1
(en)
|
1991-08-09 |
2000-03-22 |
Teikoku Hormone Mfg. Co., Ltd. |
Novel tetrapeptide derivative
|
US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
US5990325A
(en)
|
1993-03-05 |
1999-11-23 |
Florida State University |
Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
|
US6011056A
(en)
|
1991-09-23 |
2000-01-04 |
Florida State University |
C9 taxane derivatives and pharmaceutical compositions containing them
|
US5728725A
(en)
|
1991-09-23 |
1998-03-17 |
Florida State University |
C2 taxane derivaties and pharmaceutical compositions containing them
|
US5714513A
(en)
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
US5399726A
(en)
|
1993-01-29 |
1995-03-21 |
Florida State University |
Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
|
IT1254515B
(it)
|
1992-03-06 |
1995-09-25 |
Indena Spa |
Tassani di interesse oncologico, loro metodo di preparazione ed uso
|
US5831002A
(en)
|
1992-05-20 |
1998-11-03 |
Basf Aktiengesellschaft |
Antitumor peptides
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
IT1261667B
(it)
|
1993-05-20 |
1996-05-29 |
|
Tassano ad attivita' antitumorale.
|
US5955423A
(en)
|
1993-12-21 |
1999-09-21 |
The University Of Hawaii |
Cryptophycins
|
US5952298A
(en)
|
1993-12-21 |
1999-09-14 |
The University Of Hawaii |
Cryptophycins
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
US6500858B2
(en)
|
1994-10-28 |
2002-12-31 |
The Research Foundation Of The State University Of New York |
Taxoid anti-tumor agents and pharmaceutical compositions thereof
|
AU4133096A
(en)
|
1994-10-28 |
1996-05-23 |
Research Foundation Of The State University Of New York, The |
Taxoid derivatives, their preparation and their use as antitumor agents
|
US6100411A
(en)
|
1994-10-28 |
2000-08-08 |
The Research Foundation Of State University Of New York |
Taxoid anti-tumor agents and pharmaceutical compositions thereof
|
US6458976B1
(en)
|
1994-10-28 |
2002-10-01 |
The Research Foundation Of State University Of New York |
Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
|
JPH09509431A
(ja)
|
1994-11-04 |
1997-09-22 |
フアルマシア・エツセ・ピー・アー |
タキサン誘導体
|
US5473057A
(en)
|
1994-11-09 |
1995-12-05 |
The Regents Of The University Of California |
Eleutherobin and analogs thereof
|
US5599902A
(en)
|
1994-11-10 |
1997-02-04 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Cancer inhibitory peptides
|
US5580899A
(en)
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
US6156535A
(en)
|
1995-08-04 |
2000-12-05 |
University Of Ottawa |
Mammalian IAP gene family, primers, probes, and detection methods
|
US5681847A
(en)
|
1995-12-05 |
1997-10-28 |
Harbor Branch Oceanographic Institution, Inc. |
Methods of using discodermolide compounds
|
FI101923B1
(fi)
|
1995-12-05 |
1998-09-15 |
Nokia Telecommunications Oy |
Puheenvuorojen jakaminen suorakanavalla liikennöiville matkaviestimille
|
US5767297A
(en)
|
1997-02-05 |
1998-06-16 |
Ensuiko Sugar Refining Co., Ltd. |
Taxoid derivative and method of producing thereof
|
KR100561788B1
(ko)
|
1996-03-12 |
2006-09-20 |
피지-티엑스엘 컴파니,엘.피. |
수용성파클리탁셀전구약물을포함하는조성물및이러한조성물을포함하는이식가능한의료장치
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
US6133437A
(en)
|
1997-02-13 |
2000-10-17 |
Apoptogen, Inc. |
Modulation of IAPs for the treatment of proliferative diseases
|
IT1283633B1
(it)
|
1996-05-10 |
1998-04-23 |
Indena Spa |
Derivati tassanici loro sintesi e formulazioni che li contengono
|
US5919815A
(en)
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
AU710156B2
(en)
|
1996-07-15 |
1999-09-16 |
Kabushiki Kaisha Yakult Honsha |
Taxane derivatives and drugs containing the same
|
US5741892A
(en)
|
1996-07-30 |
1998-04-21 |
Basf Aktiengesellschaft |
Pentapeptides as antitumor agents
|
US5939527A
(en)
|
1996-07-30 |
1999-08-17 |
Basf Aktiengesellschaft |
Tetrapeptides as antitumor agents
|
US5821263A
(en)
|
1996-08-26 |
1998-10-13 |
Bristol-Myers Squibb Company |
Sulfenamide taxane derivatives
|
WO1999001124A1
(en)
|
1996-12-03 |
1999-01-14 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
US6380394B1
(en)
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
AU736062B2
(en)
|
1997-02-25 |
2001-07-26 |
Gesellschaft Fur Biotechnologische Forschung Mbh |
Epothilones which are modified in the side chain
|
US5886025A
(en)
|
1997-03-06 |
1999-03-23 |
Baylor University |
Anti-mitotic agents which inhibit tubulin polymerization
|
US5965537A
(en)
|
1997-03-10 |
1999-10-12 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
|
US6103698A
(en)
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
FR2761990B1
(fr)
|
1997-04-10 |
1999-06-25 |
Pf Medicament |
Derives halogenes antimitotiques d'alcaloides de vinca
|
CA2287911C
(en)
|
1997-05-15 |
2014-05-06 |
Genentech, Inc. |
Apo-2 receptor
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
US6143721A
(en)
|
1997-07-18 |
2000-11-07 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
ES2290993T3
(es)
|
1997-08-09 |
2008-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Nuevos derivados de epotilona, proceso para su produccion y su utilizacion farmaceutica.
|
JPH1192468A
(ja)
|
1997-09-17 |
1999-04-06 |
Yakult Honsha Co Ltd |
新規なタキサン誘導体
|
CA2305399A1
(en)
|
1997-10-08 |
1999-04-15 |
Bio Research Corporation Of Yokohama |
Taxoid derivatives and process for producing the same
|
US5965718A
(en)
|
1997-10-24 |
1999-10-12 |
The Scripps Research Institute |
Analogs of sarcodictyin and eleutherobin
|
WO1999032473A1
(fr)
|
1997-12-19 |
1999-07-01 |
Kabushiki Kaisha Yakult Honsha |
Derives de taxane
|
US6423689B1
(en)
|
1997-12-22 |
2002-07-23 |
Warner-Lambert Company |
Peptidyl calcium channel blockers
|
US6302838B1
(en)
|
1998-02-25 |
2001-10-16 |
Novartis Ag |
Cancer treatment with epothilones
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
US6252050B1
(en)
|
1998-06-12 |
2001-06-26 |
Genentech, Inc. |
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
|
US6258841B1
(en)
|
1998-06-29 |
2001-07-10 |
Parker Hughes Institute |
Tubulin binding compounds (COBRA)
|
US5985837A
(en)
|
1998-07-08 |
1999-11-16 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
DE19843730A1
(de)
|
1998-09-24 |
2000-03-30 |
Sueddeutsche Kalkstickstoff |
Stabilisierte, wasserlösliche Polymerpulver auf Basis von Polyoxyalkylenglykol-Carboxylaten und Verfahren zu deren Herstellung
|
US6127406A
(en)
|
1998-10-09 |
2000-10-03 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds and methods of use
|
EP1135470A2
(en)
|
1998-11-20 |
2001-09-26 |
Kosan Biosciences, Inc. |
Recombinant methods and materials for producing epothilone and epothilone derivatives
|
US6433187B1
(en)
|
1998-12-17 |
2002-08-13 |
Tularik Inc. |
Certain polycyclic compounds useful as tubulin-binding agents
|
AU2795000A
(en)
|
1998-12-22 |
2000-07-12 |
Novartis Ag |
Epothilone derivatives and their use as antitumor agents
|
DE50014587D1
(de)
|
1999-02-18 |
2007-10-04 |
Bayer Schering Pharma Ag |
16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
|
TWI270546B
(en)
|
1999-02-22 |
2007-01-11 |
Bristol Myers Squibb Co |
C-21 modified epothilones
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
US6110691A
(en)
|
2000-01-06 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Activators of caspases
|
US6414015B1
(en)
|
2000-01-28 |
2002-07-02 |
Utah State University |
Laulimalide microtubule stabilizing agents
|
US6576658B2
(en)
|
2000-02-24 |
2003-06-10 |
Harbor Branch Oceanographic Institution, Inc. |
Compositions and uses of dictyostatin compounds
|
PT1259502E
(pt)
|
2000-03-01 |
2005-05-31 |
Harbor Branch Oceanographic |
Analogos biologicamente activos da discodermolida
|
US6362217B2
(en)
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
AU2001266583A1
(en)
|
2000-05-26 |
2001-12-11 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
UA75365C2
(en)
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
US6608026B1
(en)
|
2000-08-23 |
2003-08-19 |
Board Of Regents, The University Of Texas System |
Apoptotic compounds
|
US6624317B1
(en)
|
2000-09-25 |
2003-09-23 |
The University Of North Carolina At Chapel Hill |
Taxoid conjugates as antimitotic and antitumor agents
|
AU2001293189A1
(en)
|
2000-09-29 |
2002-04-08 |
Trustees Of Princeton University |
Compositions and methods for regulating apoptosis
|
US6992063B2
(en)
|
2000-09-29 |
2006-01-31 |
The Trustees Of Princeton University |
Compositions and method for regulating apoptosis
|
WO2002030959A2
(en)
|
2000-10-13 |
2002-04-18 |
Abbott Laboratories |
Peptides derived from smac (diablo) and methods of use therefor
|
US20070292411A1
(en)
|
2000-11-08 |
2007-12-20 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
WO2002064589A1
(en)
|
2001-02-09 |
2002-08-22 |
Kosan Biosciences, Inc. |
Laulimalide derivatives
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
WO2002066033A1
(en)
|
2001-02-20 |
2002-08-29 |
Bristol-Myers Squibb Company |
Epothilone derivatives for the treatment of refractory tumors
|
US20030083263A1
(en)
|
2001-04-30 |
2003-05-01 |
Svetlana Doronina |
Pentapeptide compounds and uses related thereto
|
US20030023082A1
(en)
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
WO2002094880A1
(en)
|
2001-05-18 |
2002-11-28 |
Kirin Beer Kabushiki Kaisha |
Anti-trail-r antibodies
|
US7361341B2
(en)
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
CA2449168A1
(en)
|
2001-05-31 |
2002-12-05 |
The Trustees Of Princeton University |
Iap binding peptides and assays for identifying compounds that bind iap
|
CA2449077A1
(en)
|
2001-06-01 |
2002-12-12 |
Gregory D. Vite |
Epothilone derivatives
|
US6737409B2
(en)
|
2001-07-19 |
2004-05-18 |
Hoffmann-La Roche Inc. |
Dolastatin 10 derivatives
|
US20060258581A1
(en)
|
2001-11-21 |
2006-11-16 |
Reed John C |
Methods and composition for derepressions of IAP-inhibited caspase
|
WO2003045324A2
(en)
|
2001-11-26 |
2003-06-05 |
Kosan Biosciences, Inc. |
14-methyl-epothilones
|
US20030180296A1
(en)
|
2001-12-20 |
2003-09-25 |
Theodora Salcedo |
Antibodies that immunospecifically bind to trail receptors
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
AU2003212457A1
(en)
|
2002-03-01 |
2003-09-16 |
University Of Notre Dame |
Derivatives of epothilone b and d and synthesis thereof
|
US7211593B2
(en)
|
2002-03-12 |
2007-05-01 |
Bristol-Myers Squibb Co. |
C12-cyano epothilone derivatives
|
EP1495124A2
(en)
|
2002-04-17 |
2005-01-12 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Smac-peptides as therapeutics against cancer and autoimmune diseases
|
US20050234080A1
(en)
|
2002-05-23 |
2005-10-20 |
Coleman Paul J |
Mitotic kinesin inhibitors
|
CN100384819C
(zh)
|
2002-07-02 |
2008-04-30 |
诺瓦提斯公司 |
与细胞凋亡蛋白抑制剂结合的smac蛋白的肽抑制剂
|
AU2003265276A1
(en)
|
2002-07-15 |
2004-02-02 |
The Trustees Of Princeton University |
Iap binding compounds
|
PT1576179E
(pt)
|
2002-11-27 |
2010-12-21 |
Irm Llc |
Métodos e composições para a indução de apoptose em células cancerosas
|
US20040180828A1
(en)
|
2003-01-30 |
2004-09-16 |
Yigong Shi |
Caspase-9 : BIR domain of XIAP complexes and methods of use
|
JP2007523061A
(ja)
|
2004-01-16 |
2007-08-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Smacペプチドミメティクスおよびその使用法
|
US20110251134A1
(en)
|
2004-02-05 |
2011-10-13 |
Leigh Zawel |
Combination of (a) a dna toposomerase inhibitor and (b) an iap inhibitor
|
EP1723122B1
(en)
|
2004-03-01 |
2014-11-19 |
Board of Regents, The University of Texas System |
Dimeric small molecule potentiators of apoptosis
|
JP5122275B2
(ja)
|
2004-03-23 |
2013-01-16 |
ジェネンテック, インコーポレイテッド |
Iapのアザビシクロ−オクタンインヒビター
|
KR20080083220A
(ko)
|
2004-04-07 |
2008-09-16 |
노파르티스 아게 |
Iap 억제제
|
NZ588799A
(en)
|
2004-07-02 |
2012-06-29 |
Genentech Inc |
Inhibitors of iap
|
US7674787B2
(en)
|
2004-07-09 |
2010-03-09 |
The Regents Of The University Of Michigan |
Conformationally constrained Smac mimetics and the uses thereof
|
AU2005271831A1
(en)
|
2004-07-12 |
2006-02-16 |
Idun Pharmaceuticals, Inc. |
Tetrapeptide analogs
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
CN100427505C
(zh)
|
2004-08-19 |
2008-10-22 |
中国医学科学院基础医学研究所 |
抗人肿瘤坏死因子相关凋亡诱导配体的受体dr5单克隆抗体(ad5-10)及其制法与用途
|
KR20120127754A
(ko)
|
2004-12-20 |
2012-11-23 |
제넨테크, 인크. |
Iap의 피롤리딘 억제제
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
EP2385038A1
(en)
|
2005-02-25 |
2011-11-09 |
Tetralogic Pharmaceuticals Corporation |
Dimeric IAP inhibitors
|
US20070003535A1
(en)
|
2005-03-17 |
2007-01-04 |
Reed John C |
Methods and compositions for derepression of IAP-inhibited caspase
|
GB0506589D0
(en)
|
2005-03-31 |
2005-05-04 |
British Telecomm |
Optical fibre installation apparatus
|
DE102005017116A1
(de)
|
2005-04-13 |
2006-10-26 |
Novartis Ag |
Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)
|
CA2607940C
(en)
*
|
2005-05-18 |
2009-12-15 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
WO2006128455A2
(en)
|
2005-05-25 |
2006-12-07 |
2Curex Aps |
Compounds modifying apoptosis
|
MX2007015419A
(es)
|
2005-06-08 |
2008-02-21 |
Novartis Ag |
Compuestos organicos.
|
US20070042428A1
(en)
|
2005-08-09 |
2007-02-22 |
Stacy Springs |
Treatment of proliferative disorders
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
CN101360728A
(zh)
*
|
2005-10-25 |
2009-02-04 |
艾吉拉医疗股份有限公司 |
Iap bir结构域结合化合物
|
CA2564872C
(en)
*
|
2005-10-25 |
2010-12-21 |
Aegera Therapeutics Inc. |
Iap bir domain binding compounds
|
US8247557B2
(en)
|
2005-12-19 |
2012-08-21 |
Genentech, Inc. |
IAP inhibitors
|
EP1965865B1
(en)
|
2005-12-20 |
2018-05-16 |
Novartis AG |
Combination of an iap-inhibitor and a taxane
|
WO2007101347A1
(en)
|
2006-03-07 |
2007-09-13 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
TWI504597B
(zh)
|
2006-03-16 |
2015-10-21 |
Pharmascience Inc |
結合於細胞凋亡抑制蛋白(iap)之桿狀病毒iap重複序列(bir)區域之化合物
|
CN101443309B
(zh)
*
|
2006-03-16 |
2013-04-24 |
埃格拉医疗公司 |
Iap bir域结合化合物
|
US7807699B2
(en)
|
2006-03-21 |
2010-10-05 |
Joyant Pharmaceuticals, Inc. |
Dimeric pyrrolidine amide-containing small molecule apoptosis promoters
|
KR101071516B1
(ko)
|
2006-05-05 |
2011-10-10 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
2가 smac 모방체 및 그의 용도
|
SG171682A1
(en)
*
|
2006-05-16 |
2011-06-29 |
Aegera Therapeutics Inc |
Iap bir domain binding compounds
|
WO2008014238A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
JP5452223B2
(ja)
|
2006-07-24 |
2014-03-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
Iap阻害剤
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
CN101516904A
(zh)
|
2006-07-24 |
2009-08-26 |
泰特拉洛吉克药业公司 |
二聚的iap拮抗剂
|
US20100144650A1
(en)
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
US20100113326A1
(en)
|
2006-07-24 |
2010-05-06 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
PE20080951A1
(es)
|
2006-08-02 |
2008-09-11 |
Novartis Ag |
DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
|
JP5190062B2
(ja)
|
2006-10-12 |
2013-04-24 |
ノバルティス アーゲー |
Iap阻害剤としてのピロリジン誘導体
|
WO2008057172A2
(en)
|
2006-10-19 |
2008-05-15 |
Novartis Ag |
Organic compounds
|
JP5394249B2
(ja)
|
2006-11-28 |
2014-01-22 |
ノバルティス アーゲー |
Iap阻害剤とflt3阻害剤の組合せ剤
|
BRPI0719559A2
(pt)
|
2006-11-28 |
2014-01-21 |
Novartis Ag |
Uso de inibidores de iap para o tratamento de leucemia mieloide aguda
|
US8058272B2
(en)
|
2006-12-07 |
2011-11-15 |
Novartis Ag |
Organic compounds
|
CN101605786A
(zh)
|
2006-12-19 |
2009-12-16 |
健泰科生物技术公司 |
细胞凋亡抑制剂的咪唑并吡啶抑制剂
|
US8642554B2
(en)
|
2007-04-12 |
2014-02-04 |
Joyant Pharmaceuticals, Inc. |
Smac mimetic dimers and trimers useful as anti-cancer agents
|
WO2008128171A2
(en)
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of Michigan |
Diazo bicyclic smac mimetics and the uses thereof
|
BRPI0809867A2
(pt)
|
2007-04-30 |
2014-09-30 |
Genentech Inc |
Composto, método de indução da apoptose em uma célula, método de sensibilização de uma célula para um sinal apoptótico, método para inibir a ligação de uma proteína iap a uma proteína caspase e métodos
|
WO2008144925A1
(en)
|
2007-05-30 |
2008-12-04 |
Aegera Therapeutics Inc. |
Iap bir domain binding compounds
|
EP2058312A1
(en)
|
2007-11-09 |
2009-05-13 |
Universita' degli Studi di Milano |
SMAC mimetic compounds as apoptosis inducers
|
WO2009136290A1
(en)
|
2008-05-05 |
2009-11-12 |
Aegera Therapeutics, Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
BRPI0912692A2
(pt)
|
2008-05-16 |
2017-03-21 |
Dana Farber Cancer Inst Inc |
imunomodulação através de inibidores de iap
|
TW201011006A
(en)
|
2008-06-16 |
2010-03-16 |
Nuevolution As |
IAP binding compounds
|
US20110171171A1
(en)
*
|
2008-06-27 |
2011-07-14 |
Aegera Therapeutics, Inc. |
Bridged secondary amines and use thereof as iap bir domain binding compounds
|
WO2010015090A1
(en)
|
2008-08-07 |
2010-02-11 |
Aegera Therapeutics Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
NL2001882C2
(nl)
|
2008-08-12 |
2010-02-15 |
Heineken Supply Chain Bv |
Tapkop, tapinrichting en werkwijze voor gebruik van een tapinrichting.
|
US20110177060A1
(en)
|
2008-09-19 |
2011-07-21 |
Aegera Therapeutics, Inc. |
Iap bir domain binding compounds
|
AU2011214057B2
(en)
*
|
2010-02-12 |
2016-11-17 |
Pharmascience Inc. |
IAP BIR domain binding compounds
|